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Abstract
Cancer is one of the leading causes of death worldwide. In the last two decades, the 
development of nanotechnology has facilitated our ability to design new nanoparticles 
for the diagnosis and treatment of cancer. In this chapter, we reviewed the applications 
of gold nanoparticles as contrast agents for cancer imaging, including optical imaging, 
photoacoustic imaging, and X-ray–based imaging. We also reviewed their applications 
as delivery carriers for small molecule drugs, therapeutic genes, vaccines, and adjuvants 
and as therapeutic agents by themselves in cancer treatment, including photothermal 
therapy, photodynamic therapy, and radiation therapy.
Keywords: gold nanoparticles, cancer, cancer imaging, cancer treatment, localized surface 
plasmon resonance
1. Introduction
With over 7 million new deaths per year, cancer remains one of the leading causes of death 
worldwide. The mortality of cancer is estimated to reach 13.1 million in the next two decades. 
Surgery, radiation therapy, and chemotherapy are key players in treatment of cancer. These 
treatments slow the progression of disease and prolong the survival of patients. Nonetheless, 
new treatments are in urgent need due to the greater understanding of the complexity of 
genetic and environmental factors. Recently, the development of nanotechnology has facili-
tated our ability to design new nanoparticles for the diagnosis and treatment of cancer [1].
Due to their unique physical and chemical properties, gold nanoparticles (ranging from 
1 to 100 nm in one dimension at least) have attracted remarkable attention in recent years 
[2]. The gold nanoparticles are suitable for drug delivery given their large surface area to 
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volume ratio. Owing to localized surface plasmon resonance (LSPR), gold nanoparticles, 
such as gold nanorods, nanocages, nanoshells, and nanostars, have strong light scattering 
and/or absorbance and have been extensively explored for bioimaging, cancer treatment, 
and both. In addition, given the strong binding affinity of gold to thiol and amine groups, 
the surface of gold nanoparticles can be easily functionalized with biomolecules such as 
DNA, siRNA, peptides, antibodies, and receptors. Gold nanoparticles also have a long his-
tory for clinical applications (for the treatment of rheumatoid arthritis) [3].
2. Gold nanoparticles in cancer imaging
2.1. Light scattering–based imaging
The scattering cross section of gold nanoparticles increases with the growth of their size. In 
general, gold nanoparticles can scatter light with the cross section more than 1 million times 
stronger than that of the emission from a fluorescent dye. Gold nanoparticles with a diameter 
greater than 10 nm can be visualized by dark-field scattering microscopy. Compared to a 
fluorescent dye, the gold nanoparticles are photostable and the scattering light does not blink. 
These features make gold nanoparticles attractive imaging probes for optical imaging.
Different shapes of gold nanoparticles, such as gold nanorods, nanocages, and nanostars, have 
been tested by dark-field scattering microscopy. In 2003, Sokolov et al. [4] conjugated antibod-
ies against epidermal growth factor receptor (EGFR), a glycoprotein that is overexpressed in 
epithelial malignant cells, for molecular-specific optical imaging. The gold nanoparticles they 
used were ~12 nm in diameter, which is approximately the same size as that of antibodies. 
The EGFR-overexpressed cells can be visualized individually by the strong scattering light 
reflected from a laser pointer with power output less than 5 mW. Later, El-Sayed et al. [5] 
demonstrated that the anti-EGFR antibodies–conjugated gold nanoparticles can differentiate 
EGFR-overexpressed malignant cells from healthy cells by simple dark-field optical micros-
copy. Other gold nanoparticles with different size and shapes were also explored. As dem-
onstrated by Huang et al. [6], gold nanorods could scatter light in near-infrared (NIR) region 
and thus enable detection of head and neck cancer cells in biological tissues. In this work, 
they found that the extinction spectra of the gold nanorods on the cell surface were greatly 
red-shifted compared with that of free nanorods of the same size. This red shift is believed 
to rise from the change in the local refractive index after binding between gold nanopar-
ticles and cells or the interparticle interaction between the gold nanorods on the cell sur-
face. By conjugation, gold nanostars with hyaluronic acid, our group [7] demonstrated that 
CD44-overexpressed malignant cells could be observed under dark-field optical microscopy 
through the binding between cell surface receptor and functionalized gold nanostars.
Another imaging modality based on light scattering is optical coherence tomography (OCT). 
OCT captures the changes in phase and intensity from the scattered light to provide opti-
cal cross-sectional images of tissues. It employs NIR light to produce a three-dimensional 
image of tissues with micrometer resolution. Gobin et al. [8] demonstrated dramatic contrast 
Noble and Precious Metals - Properties, Nanoscale Effects and Applications292
enhancement of tumors on OCT images after systematically injected gold nanoshells. The 
quantification of OCT images showed a 56% increase in tumor intensity 20 h after the injec-
tion of gold nanoshells. In contrast, conventional optimal contrast agents for OCT, such as 
microbubbles and microspheres, typically enhance contrast less than 5% in vivo. Cang et al. [9] 
described that gold nanocages with a 35 nm edge length can provide enhanced contrast for 
OCT in tissue phantoms. Similarly, gold nanorods with LSPR wavelengths overlapping the 
OCT light source have been demonstrated for OCT contrast enhancement [10]. One interest-
ing observation in that report is that the gold nanorods generate little signal when the wave-
length of OCT source is outside their spectral bandwidth. This result indicates the possibility 
of spectral multiplexing for contrast-enhanced OCT.
2.2. Photoacoustic imaging
The photoacoustic imaging (PAI) is based on the acoustic waves generated by the thermal 
expansion of materials induced by optical excitation. When a pulsed laser irradiates mate-
rials, the temperature rise of the materials produces ultrasonic waves by periodic thermal 
expansion. The images of PAI are then constructed by detection of the ultrasonic waves. Since 
the ultrasonic wave penetrates deeper than light in tissues, the imaging volume and depth of 
PAI are significantly higher than those of optical imaging.
Gold nanoparticles have been highly attractive for PAI due to their excellent photothermal 
conversion ability and tunable optical properties. Jokerst et al. [11] visualized photoacoustic 
signal from gold nanorods accumulated in ovarian cancer tumors in vivo by PAI. The increase 
fold of photoacoustic signal was in good linear relationship with the concentration of intrave-
nously injected gold nanorods (R2 = 0.97). Song et al. demonstrated the use of gold nanocages 
as lymph node tracers for PAI. They identified gold nanocages labeled sentinel lymph nodes 
as deep as 33 mm below the skin surface in an animal model. Our group worked with Lin 
and coworkers [12] demonstrated that gold vesicles composed of assembled gold nanopar-
ticles have strong photoacoustic signal due to the plasmonic coupling between the adjacent 
gold nanoparticles in the vesicular membranes. To specifically target tumor neovasculature, 
our group worked with Nie and coworkers [13] to functionalize gold nanostars with cyclic 
arginine-glycine-aspartic acid (cRGD) peptides, which possess high affinity to integrin α
v
β
3
 
overexpressed by neovessels of tumors. As shown in Figure 1, benefited from targeting abil-
ity of cRGD-conjugated gold nanostars, three-dimensional photoacoustic images of tumor 
neovessels could be obtained with high spatial resolution and deep imaging depth (up to 
centimeters under skin) using a laser fluence of 6 mJ/cm2, which is far less than the safety 
limit for laser skin exposure (20 mJ/cm2). Another work from our group designed pH (low) 
insertion peptides (pHLIPs)-conjugated gold nanostars for tumor targeting PAI [14]. pHLIPs 
are 35 amino acid peptides with pH-dependent transmembrane activity. After conjugation, 
the functionalized gold nanostars could be activated in the mild acidic microenvironment of 
tumors and internalized by cells rapidly. The photoacoustic images showed that at 24 h after 
systematic injection, the pHLIPs-conjugated nanostars had a 50% higher tumor signal than 
the gold nanostars without functionalization.
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2.3. X-ray–based imaging
Computed tomography (CT) is one of the most widely used diagnostic imaging modalities 
for cancer. It can obtain whole volume 3D anatomical images with high spatial resolution in 
a cost-effective fashion. However, the contrast between different types of soft tissues is poor 
on CT images; thus, contrast agents, like iodine-based compounds, need to be injected to dif-
ferentiate tumors from healthy tissues.
Since the attenuation of X-rays depends greatly on the atomic numbers of elements, gold has 
a stronger X-ray attenuation coefficient than other elements naturally existed in human bod-
ies. Therefore, the accumulation of gold nanoparticles in tumors can significantly increase 
X-ray attenuation, resulting in high contrast between tumor and healthy tissues on CT images. 
Deoxyglucose-labeled gold nanoparticles are described as potential CT contrast agents [15]. 
The cancer cell samples showed significant contrast enhancement after incubation with these 
gold nanoparticles on multiple CT slices. The use of acetylated dendrimer-entrapped gold 
nanoparticles to image cancer in vivo is also reported [16]. The gold nanoparticles with a mean 
diameter of 2.6 nm were able to increase the attenuation of tumors after intratumoral and intra-
peritoneal administration in a mice model of human lung adenocarcinoma. Our group dem-
onstrated that PEGylated gold nanostars have higher CT values when compared to iodixanol 
at equivalent concentration. The CT images of tumor-bearing mice exhibited 10-fold enhance-
ment in tumors after injection of PEGylated gold nanostars (Figure 2) [17]. We also reported 
the use of Gd chelates–conjugated gold nanoprisms as a new class of contrast agents for CT/
MRI dual-modality imaging [18]. The CT values of Gd chelates–conjugated gold nanoprisms 
had a linear relationship with the concentration of gold at an attenuation coefficient calculated 
to be 959.3 HU L g−1. The conjugated Gd chelates exhibited high T1 relaxivity for MR imaging.
The surface of gold nanoparticles can be easily functionalized with tumor-targeting moieties, 
such as ligands, antibodies, and aptamers, to selectively image tumors via active targeting 
strategy. For example, Hainfeld et al. [19] conjugated gold nanoparticles with  polyethylene 
Figure 1. cRGD-conjugated gold nanostars for PAI. (a) Sequential photoacoustic images captured before, 2, 6, and 24 h 
post injection of RGD-GNS, control peptide–conjugated gold nanostars (RAD-GNS), and PEGylated gold nanostars 
(GNS-PEG). (b) Quantification of the signal intensity in region of interest. Reproduced from Ref. [13].
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glycol (PEG) and anti-Her2 antibodies (Herceptin) as Her2-targeting diagnostic tools. 
An in vitro study showed the nanoconjugates specifically targeting Her2-positive breast 
cancer BT-474 cells vs. Her2-negative breast cancer MCF7 cells with a gold mass ratio of 
39.4 ± 2.7:1. In the in vivo studies, the BT-474 tumors showed 1.6 times higher CT attenuation 
than MCF7 tumors after intravenous injection of anti-HER2–conjugated gold nanoparticles. 
The Housefield Unit (HU) of BT-474 tumors was 22-fold higher than that of surrounding 
muscles, enabling the detection of small tumors on micro-CT. In another report, Kim et al. 
[20] functionalized gold nanoparticles with a prostate-specific membrane antigen (PSMA) 
RNA aptamer to establish prostate cancer targeting CT probes. The aptamer-conjugated 
gold nanoparticles exhibited fourfold higher CT values in PSMA-overexpressed LNCaP 
cells than that in PSMA negative PC3 cells. Furthermore, the aptamers on gold nanopar-
ticles could be used to load doxorubicin to kill targeted cells more efficiently.
Figure 2. Amino-PEG functionalized gold nanostars (GNS-PEG-NH
2
) for X-ray and CT imaging. (a) and (b) X-ray and 
CT images of MCF-7 tumor-bearing mice after intratumoral of PBS and GNS-PEG-NH
2
. (c) Corresponding CT values of 
tumors in (b). Reproduced from Ref. [17].
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3. Gold nanoparticles in drug delivery
3.1. Small molecule drug delivery
Gold nanoparticles have been explored as drug carriers due to the following advantages: (1) the 
large surface area provides high loading capacity for drug loading and improves the hydrophi-
licity and stability of drugs; (2) the ability to modify surface with targeting ligands to enhance the 
tumor selective accumulation compared to free drugs; (3) the passive targeting ability to tumor 
site due to their leaky neovessels, which is called enhanced permeability and retention(EPR) 
effect; and (4) the controlled release of loaded drugs in response to internal or external stimulus.
The enhanced tumor accumulation of gold nanoparticles can be utilized for drug delivery to 
increase therapeutic potent and reduce side effects. Xiao et al. [21] demonstrated that cRGD-
conjugated gold nanorods selectively delivered doxorubicin to tumors with a tumor/muscle 
ratio as high as 16.6 ± 1.2 at 5 h post injection. Given that the nanorods were labeled with 
radioactive 64Cu, the biodistribution of nanorods could be easily observed and quantified by 
microPET/CT in vivo. In another work, You et al. [22] connected TNYL-RAW, a 14-mer peptide 
with high binding affinity to EphB4, with doxorubicin-loaded gold nanoshells. Since EphB4 is 
a receptor overexpressed by numerous types of tumor, such nanoshells selectively delivered 
doxorubicin to Hey tumors in nude mice model at 24 h after intravenous injection.
Gold nanoparticles can release loaded drugs in response to external stimulus like light. You 
et al. [23] reported successful loading of doxorubicin on gold nanoparticles and nanoshells 
after 24 h of mixing at room temperature. Interestingly, they found that the payload of doxo-
rubicin is exceptionally high (up to 70%) in gold nanoshells than that in gold nanoparticles 
(~20%). They believed the hollow interior of the nanoparticles increased the effective surface 
area for the high payload loading of doxorubicin. Furthermore, the release of doxorubicin 
can be triggered by NIR laser irradiation to selectively increase the drug amount in tumors. 
Similarly, Yavuz et al. [24] used the hollow interiors of gold cages to load doxorubicin and 
covered the surface of gold nanocages with thermoresponsive polymers to prevent the pre-
loading doxorubicin leaked from the porous walls. Such design enables the gold nanopar-
ticles to release drugs in an NIR laser controlled fashion.
Some gold nanoparticles are designed to behave dramatically to various internal stimuli in 
the microenvironment of tumors. For instance, Wang et al. [25] tethered doxorubicin onto gold 
nanoparticles with a PEG spacer via an acid-labile linkage. They found that this smart drug 
carrier could release doxorubicin in response to the low pH of endosome and enhance thera-
peutic efficacy by overcoming the drug resistance of MCF-7/ADR cancer cells.
3.2. Gene delivery
Gene therapy attempts to treat cancer by altering the dysregulated gene expression of tumor 
cells. The successful regulation of gene expression requires compaction of DNA/RNA, rapid 
cellular uptake and endosomal escape, protection from degradation in blood stream and cyto-
plasm, and effective delivery of DNA/RNA to the nucleus. Therefore, carriers for efficient and 
safe DNA/RNA delivery are critical for the development of gene therapy.
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Gold nanoparticles provide a potent platform for therapeutic gene delivery. Braun et al. 
[26] coated 40 nm gold nanoshells with siRNA and Tat peptide-lipid cell internalizing 
agents to silence gene expression in a particular subset of cells. They showed that the gene 
silencing can be temporally and spatially controlled using a pulsed NIR laser via light-
induced siRNA release. Jensen et al. [27] complexed a high-density monolayer of siRNA on 
the surface of gold nanoparticles, a nanostructure so-called spherical nucleic acid (SNA), 
to knockdown the expression of oncoprotein Bcl2Like12 (Bcl2L12) of glioma cells. The 
in vitro studies showed SNAs accumulated in human glioma U87MG cells efficiently and 
neutralized Bcl2L12, a potent caspase and p53 inhibitor specifically overexpressed by the 
majority of human primary gliomas, without any chemical modifications and auxiliary 
transfection methods. After intravenous injection, the SNAs penetrated the blood-brain 
barrier, disseminated throughout glioma explants, inhibited Bcl2L12 expression in glioma 
and reduced tumor volume in mice model, without adverse side effects. To specifically 
deliver siRNA to tumors, our group constructed a CD44-targeting heat shock protein 72 
(Hsp72) depletion nanosystem by assembling gold nanostars with siRNA against Hsp72 
and hyaluronic acid, a targeting moiety binds to CD44, in a layer-by-layer manner [7]. We 
showed that the obtained nanosystem could selectively inhibit the expression of Hsp72 in 
triple negative breast cancer (TNBC) cells, sensitize TNBC cells to hyperthermia and 
enhance the therapeutic efficacy of photothermal therapy with minimal side effect both 
in vitro and in vivo.
3.3. Adjuvant and vaccine delivery
Immunotherapy is a burgeoning therapeutic modality for cancer treatment. The goal of 
immunotherapy is to harness the host immune system to attack and eradicate cancer cells 
[28]. There are several ways to enhance the innate power of immune system to fight cancer. 
Using cancer vaccine is one of the most extensively studied approaches to boost the immune 
system’s response [29].
Gold nanoparticles are promising for delivery of cancer vaccine, because they preferentially 
accumulate within tissues and cells of the immune system, and have a large surface area for 
vaccine loading. Lin et al. [30] conjugated large quantities of self-assembled tumor-associated 
peptides on the surface of gold nanoparticles as a cancer vaccine platform. The so-called gold 
nanovaccines were able to effectively deliver antigens to dendritic cells (DCs) and stimulated 
cytotoxic T lymphocytes (CTL) better than free peptides.
Since the tumor cells can secrete immunosuppressive cytokines and/or attract immune sup-
pressive cells to evade the attack from immune system, co-delivery of adjuvants with vaccine 
has been explored to elicit a stronger CTL response to existing tumors. In one study, Lee 
et al. connected red fluorescent protein (RFP, as a model cancer antigen) and CpG oligodeoxy-
nucleotide (CpG ODN, a short single-stranded synthetic DNA used as vaccine adjuvant) on 
7 nm gold nanoparticles [31]. The nanoparticles were injected via footpad to RFP-expressing 
B16F10 melanoma tumor-bearing mice. After interacted with DCs, remarkable antitumor 
activity was induced through a Th1-mediated cell response. In another report, gold nanopar-
ticles were conjugated with both tumor-associated glycopeptides antigens and a peptide from 
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complement derived protein C3d to act as an adjuvant to activate B-cells [32]. The immunized 
mice represented robust immune response with production of immunoglobulins, containing 
both IgM and IgG isotypes.
4. Gold nanoparticles in cancer treatment
4.1. Photothermal therapy
Photothermal therapy (PTT) is a central application of gold nanoparticles in cancer treatment. 
Gold nanoparticles absorb incident photons and convert them to heat to destroy cancer cells. 
Due to their unique optical properties as a result of LSPR, gold nanoparticles absorb light 
with extremely high efficiency (cross section at ~10 9 M−1 cm−1), which ensures effective PTT at 
relatively low radiation energy. The abnormal vascular structure of tumor is inefficient in dis-
sipating heat, thus the tumors are more sensitive to hyperthermia than healthy tissues. When 
irradiated by light, the heat generated by gold nanoparticles causes biomolecule denaturation 
and cellular membrane disruption and kills tumor cells [33].
The wavelength of incident light is important for PTT. The NIR light has maximal penetration 
in tissues because most components of biotissues, including water, hemoglobin, skin, and 
other pigments, show minimal absorption and scattering of light in this region. Typically, the 
NIR light can reach ~1 cm deep in human body. Various nanoparticles that can absorb NIR 
light have been synthesized and tested for PPT, including nanorods, nanoshells, nanocages, 
nanostars, nanovesicles, and so on. Hirsch et al. [34] demonstrated that PEGylated silica@Au 
gold nanoshells induced irreversible thermal damage to tumor under exposure to low dose of 
NIR light (4 W/cm2) for 4–6 min after systematic injection. Without nanoshells, the exposure 
of NIR light increased temperature less than 10°C. In the in vivo studies, the temperature of 
tumor was monitored by MRI in real time, and the maximal depths of thermal damage span-
ning were about 4–6 mm after 6 min of irradiation.
Selective PTT has been demonstrated by using tumor-targeting gold nanoparticles. One strat-
egy for selective PTT is to design immune-targeted gold nanoparticles against receptors over-
expressed by cancer cells. For instance, in an experiment designed by Huang et al., [6] gold 
nanorods were conjugated to anti-EGFR antibodies, incubated with malignant oral epithelial 
cells (HOC 313 clone 8 and HSC 3) and normal epithelial cells (HaCat), followed by exposure 
to NIR laser at 800 nm. It is found that HOC 313 clone 8 and HSC 3 destroyed at about half 
the laser energy required to destroy HaCat cells. Another strategy is using engineered gold 
nanoparticles responsible to the microenvironment of tumors. Nam et al. [35] synthesized a 
hydrolysis-susceptible citraconic amide moiety and introduced to the surface of 10-nm sized 
gold nanoparticles. After internalization by cancer cells, the obtained “smart” gold nanoparti-
cles exhibited both positive and negative charges in response to the low pH of endosomes. Then, 
the electrostatic between the nanoparticles induced rapid aggregation and shifted the absorp-
tion to NIR region. In this way, the gold nanoparticles can selectively destroy cancer upon 
NIR laser irradiation. In another report from our group [36], gold nanostars were decorated 
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with long-chain amine/carboxyl-terminated PEG. Such gold nanostars were designed to 
change cell affinity reversibly in response to the change of extracellular pH by utilizing the 
reversible protonation of amine and carboxyl groups. After intravenous injection, these gold 
nanostars showed enhanced tumor accumulation and photothermal therapeutic efficacy than 
that of pH-insensitive PEGylated gold nanostars.
One strategy to increase the therapeutic index of PTT is to increase the photothermal con-
version efficacy of gold nanoparticles. Higher photothermal conversion efficacy means 
lower laser power density required for tumor ablation and less damage to skin and other 
healthy tissues. Chen et al. [37] found that the photothermal conversion efficacy decreases 
as the effective radius of gold nanorods increases. The highest conversion efficacy (~95%) 
was determined in gold nanorods with size of 10 × 38 nm. In another report [38], the con-
version efficacy is 21% for gold nanorods with size of 7 × 23 nm. Therefore, the conversion 
efficacy of gold nanoparticles is highly dependent on their size and shape. Huang et al. [39] 
reported the synthesis of gold bellflowers by a liquid-liquid-gas triphase interface system. 
The gold bellflowers showed photothermal conversion efficiency at 74%, which is higher 
than most reported gold nanoparticles. Ma and coworkers working with our group [40] 
demonstrated similar photothermal conversion efficiency (~70%) in triangular gold nano-
prisms (Figure 3).
Reversing the thermoresistance of malignant cells is another pathway to enhance the thera-
peutic effect of PTT. Recently, Wang et al. [41] complexed gold nanorods with siRNA against 
BAG3, a cytoprotective protein preventing cell death from hyperthermia, to sensitize cancer 
cells to PTT treatment. They demonstrated that the gold nanorods-siRNA complex enhanced 
apoptosis and antitumor effect of PTT both in vitro and in vivo by knocking down the expres-
sion of BAG3 in tumor cells. Our group entrapped siRNA against Hsp72, a key chaperone 
for the thermoresistance of cells, onto the surface of gold nanostars [7]. We showed that the 
siRNA functionalized gold nanostars sensitized breast cancer cells to hyperthermia and sig-
nificantly enhanced the therapeutic efficacy. Similarly, Chen et al. [42] loaded a small mol-
ecule Glut1 inhibitor of diclofenac (DC) on the surface of gold nanorods. The DC depleted 
the Glut1 level in tumor cells, blocked glycolysis, decreased ATP level, and finally inhibited 
the expression of heat shock proteins (Hsp). Without the protection from Hsp, the tumor cells 
were more easily to be destroyed by PTT.
Due to the effect of surface melting, gold nanoparticles may undergo laser-induced shape 
transformation far below the bulk melting point and lose the photothermal conversion abil-
ity. Gold nanoparticles are easier to reshape under irradiation of a pulse laser than under 
that of a continuous wave laser because the light energy is harder to release from the lat-
tice of gold nanoparticles to surrounding tissues upon pulse laser irradiation [43]. Takahashi 
et al. [44] demonstrated that gold nanorods were reshaped into spherical nanoparticles under 
pulsed NIR laser irradiation and did not kill cells upon successive laser irradiation. Wang 
et al. compared the photothermal stability of gold nanorods, nanohexapods, and nanocages 
under pulsed laser irradiation. They showed that gold nanorods started to melt at 15 mW/cm2, 
whereas nanohexapods and nanocages started to melt at 25 mW/cm2. Chen et al. [45] found 
that gold nanocages were stable under continuous wave laser but melt to nanoparticles under 
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pulse laser. Thus, the type of laser and the photothermal stability of gold nanoparticles should 
be considered in practical applications of PTT.
4.2. Photodynamic therapy
The principle of photodynamic therapy (PDT) has been known for over 100 years. PDT 
involves three nontoxic components, photosensitizer, light, and oxygen, that are needed to 
generate singlet oxygen (1O
2
) or/and reactive oxygen species (ROS) to kill cells. Generally, the 
photosensitizer is administrated to localize in tumor first, activated by light of a specific wave-
length to transfer energy from light to molecular oxygen, and damage cells by the generated 
1O
2
 and ROS. Since 1O
2
 and ROS quench after a very short time, PDT is a localized treatment 
similar to PTT. However, due to the poor solubility of most photosensitizers, it is challenging 
to deliver them to tumor with high specificity for treatment.
To address this challenge, gold nanoparticles are engineered as carriers of photosensitizer. 
Camerin et al. [46] bound Zn(II)-phthalocyanine disulfide (C11Pc), a photosensitizer bearing 
Figure 3. PEGylated gold nanoprism for PTT. (a) and (b) Representative TEM images of PEGylated gold nanoprism. (c) 
Heating curves of various concentration of PEGylated gold nanoprism under laser irradiation. (d) Photostability of gold 
nanoprism under five cycles of laser irradiation. Reproduced from Ref. [40].
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hexyl chains and a sulfur terminated C11 chain, with gold nanoparticles and investigated the 
photodynamic therapeutic effect in a melanoma mice model. Compared with free C11Pc, the 
ratio between the amount of photosensitizer recovered from melanoma and skin increased 
from 2.3 to 5.5 for gold nanoparticles bound C11Pc at 24 h after injection. The nanoparti-
cle-bound C11Pc also showed a better antitumor effect than that of free C11Pc at the same 
concentration.
With rational design, the PDT and PTT effect of photosensitizer-loaded gold nanoparticles 
can be combined to further enhance the therapeutic efficacy via synergistic effect. Jang et al. 
[47] developed a gold nanorods-photosensitizer complex (GNR-AlPcS4) for PDT/PTT dual-
modality treatment. In in vitro studies, GNR-AlPcS4–treated cells showed fourfold greater 
intracellular uptake and enhanced therapeutic efficacy than that of free AlPcS4-treated cells. 
After intravenous injection of GNR-AlPcS4, PDT and PTT effect can be induced by irradia-
tion of 670 and 810 nm laser separately. Compared with PDT alone, the tumor growth inhi-
bition increased from 79 to 95% for PDT/PTT treatment. Our group covalently conjugated 
Chlorin e6, a commonly used photosensitizer, with gold nanostars [48]. The peak of LSPR 
of gold nanostars was tuned to match the absorbance of Chlorin e6. Such design enables the 
simultaneous activation of PDT and PTT effect upon irradiation of single wavelength NIR 
laser (Figure 4). Our results demonstrated that the photostability of photosensitizers and gold 
nanostars is different, and thus the ratio between PDT and PTT effect can be modulated by 
adjusting irradiation time. The synergistic PDT/PTT effect significantly enhanced the thera-
peutic efficacy and inhibited the growth of breast cancer in animal models.
Certain gold nanoparticles have the ability to generate 1O
2
 and ROS upon light irradiation, 
allowing them to act as photosensitizers by themselves rather than as delivery vehicles. 
Krpetić et al. [49] showed endosomal gold nanoparticles disrupted endosome and distributed 
into cytosol of cancer cells upon low-intensity laser irradiation. They ruled out the possibility 
of photothermal effect as the underlying mechanism due to the low intensity of laser used in 
their experiments and observed higher concentration of ROS in the cells incubated with gold 
nanoparticles than in the control cells incubated without nanoparticles after laser irradiation. 
Pasparakis [50] found that the gold nanoparticles, with a mean diameter of 40 nm, could 
generate 1O
2
 upon either pulse or continuous wave laser irradiation. Cancer cell death was 
observed after incubation with gold nanoparticles, followed by laser irradiation. Although 
these reports demonstrated the potential of using gold nanoparticles as photosensitizers in the 
future, the wavelengths of light used in these experiments are 514 and 532 nm. The poor pen-
etration ability of light in this wavelength region limits their potential for in vivo applications.
4.3. Photon-based radiation therapy
Radiation therapy (RT) is a major component of the modern therapeutic modalities of can-
cer. Photon-based radiation therapy uses high-energy gamma rays, typically 8–18 MeV for 
deep tumors, to control the growth of tumor by causing DNA damage via direct ionization or 
through production of free radicals and secondary electrons [51]. Since gamma rays have a 
low linear energy transfer (LET, energy deposited per unit distance traversed), a large fraction 
of radiation dose deposits in healthy tissue before and behind the planned target volume [52].
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When gamma rays excited core electrons near the atomic nucleus of elements, low energy 
electrons may be released by a so-called Auger de-excitation processes. Gold nanoparticles 
have high atomic number and are more likely to generate Auger electrons when compared to 
light elements of biological tissues. The Auger electrons are effective in breaking DNA and only 
damage cells in a short distance less than the size of a single cell. This short-range therapeu-
tic effect makes gold nanoparticles potent to selectively sensitize tumor cells to photon-based 
radiation therapy. Hainfeld et al. [53] demonstrated the use of gold nanoparticles with a mean 
diameter of 1.9 nm for enhancement of radiation therapy. After a single intravenous injection of 
gold nanoparticles, the tumor-to-normal tissue gold concentration ratios reached about 8:1. The 
1-year survival of mice bearing EMT-6 breast cancer increased from 20% (with X-rays alone) to 
86% (sensitized by gold nanoparticles) after several minutes of 250 kV gamma ray irradiation. 
The nanoparticles treated mice presented no overt clinical signs for more than 1 year.
One problem of using ultrasmall nanoparticles is the relatively short half-life due to the rapid 
excretion from kidney. To reduce the dosage of gold, larger nanoparticles with tumor-targeting 
moieties have been exploited. In one study, thio-glucose bound gold nanoparticles were 
synthesized as a sensitizer to enhance radiation therapy for ovarian cancer cells [54]. Since 
Figure 4. Chlorin e6-conjugated gold nanostars (GNS-PEG-Ce6) for PDT/PTT. (a) Schematic representation of PDT/PTT 
upon single laser irradiation. (b) Thermal images of MDA-MB-435 tumor-bearing mice under laser irradiation. (c) Digital 
photos and H&E stained tumor sections collected from each group of mice at the 8th day post treatment. (d) Tumor 
growth curves of each group after treatment. Reproduced from Ref. [48].
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malignant cells metabolize faster than healthy cells, the glucose coating of gold nanoparticles 
resulted in an ~31% increase of cell uptake compared to that of naked nanoparticles. As a 
result, the inhibition of cell proliferation increased 30.48% for 90 kV and 26.88% for 6 MV 
gamma ray irradiation. In another report, 30 nm gold nanoparticles were conjugated to 
Herceptin, a monoclonal antibody against Her2, to target MDA-MB-361 in a subcutaneous 
mice model [55]. After gamma ray irradiation, the tumors treated with gold nanoparticles 
resulted in 46% tumor regression, whereas the tumors treated by gamma ray alone increased 
16% in tumor volume.
Although larger gold nanoparticles achieve improved accumulation in specific tumors due to 
the EPR (enhanced penetration and retention) effect, some authors argue that as gold nanopar-
ticles become larger, more of the secondary electrons occur in the core of the nanoparticles, 
thus reducing the dose delivered to the cytoplasm around the nanoparticles. Therefore, the 
best size range of gold nanoparticles for photon-based radiation therapy is still under debate.
4.4. Ion-based radiation therapy
Ion-based radiation therapy is another type of RT. Instead of utilizing high-energy gamma 
rays, ion-based radiation therapy uses ion beams as the radiation source, such as the ions of 
hydrogen (protons), helium, carbon, or oxygen. The ion radiation is attractive because it has 
a strong LET near the end of the track, which is called the Bragg peak. The location of Bragg 
peak can be extended by increasing the energy of the ion so that the volume of irradiation can 
be better defined in ion irradiation than in photon irradiation.
One of the proposed mechanisms for radiosensitization of gold nanoparticles is that the ion 
beams excite surface plasmons and thus increase the yield of secondary electrons. Li et al. [56] 
demonstrated the radiosensitization effect of gold nanoparticles for proton therapy in vitro. They 
compared the difference between effect of gold nanoparticles with different size (5 and 10 nm) 
and proton beams with different LET (10 and 25 keV μm−1). A pronounced radiosensitization 
effect of gold nanoparticles was observed after irradiation of proton beam with high LET, but 
not with low LET. The effect was more remarkable for large gold nanoparticles than for small 
gold nanoparticles. Recently, Lin et al. established a biological model of gold nanoparticles–
enhanced proton therapy [57]. They suggested that the radiosensitization effect would only exist 
when the gold nanoparticles were internalized into cells, especially into cell nucleus. Kim et al. 
[58] intravenously injected 14 nm gold nanoparticles into CT26 tumor bearing mice and utilized 
proton beam to irradiate CT26 tumor at 24 h post injection. They observed 100% complete tumor 
regression (CTR) in mice treated with a proton dose of 31 Gy and tumoral gold concentration of 
41 Au/g tissues. In contrast, the CTR was 37–62% for mice treated by proton alone.
5. Future perspectives
As discussed above, the extensive research on gold nanoparticles over the past decade has 
indicated their potential for a rich variety of applications in cancer imaging and treatment. 
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Many advances were enabled by the understanding of the chemical synthesis and biobehav-
ior of gold nanoparticles. These understandings will certainly lead to more practical clinical 
applications. The use of gold nanoparticles for drug delivery and photothermal therapy was 
proved for phase I and phase II clinical trials [59].
Although gold nanoparticles offer an attractive platform for new novel modalities for cancer 
imaging and treatment, it is very important to carefully and precisely study their toxicity in 
potential applications for human. Although the gold is relatively inert for biotissues, these 
nanoparticles tend to remain in the body, especially in liver and spleen for a long time. Thus, 
the long-term toxicity of nanoparticles is an issue for their use in humans. Since the reported 
biodistribution and toxicity vary greatly with the size, shape, and coating of gold nanopar-
ticles, it seems that the safety of gold nanoparticles is dependent on many factors, and so, this 
needs to be examined for every single synthetic formula and application [60].
One unique property of gold nanoparticles is their LSPR effect, which enables a variety 
of imaging and treatment modalities, such as light scattering imaging, photothermal ther-
apy, photodynamic therapy, and so on. However, the penetration depth of light in biotis-
sues is no more than several centimeters and cannot reach most tumors in human body. 
Combining other imaging and therapeutic modalities may provide a strategy to overcome 
this limitation [61].
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